SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Themis Medicare - Quaterly Results

14 May 2024 Evaluate
The company witnessed a 22.11% growth in the revenue at Rs. 978.18 millions for the quarter ended March 2024 as compared to Rs. 801.05 millions during the year-ago period.Net profit of the cmpany stood at Rs. 30.92 millions for the quarter ended March 2024 a decline of -48.83% from Rs. 60.43 millions  in the same quarter last year.Operating Profit reported a sharp decline to 104.14 millions from 134.34 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 978.18 801.05 22.11 3817.61 3543.23 7.74 3817.61 3543.23 7.74
Other Income 11.00 29.47 -62.67 47.56 115.05 -58.66 47.56 115.05 -58.66
PBIDT 104.14 134.34 -22.48 562.89 789.67 -28.72 562.89 789.67 -28.72
Interest 21.61 27.08 -20.20 93.76 95.64 -1.97 93.76 95.64 -1.97
PBDT 82.53 107.26 -23.06 469.13 694.03 -32.40 469.13 694.03 -32.40
Depreciation 30.55 27.96 9.26 122.46 104.95 16.68 122.46 104.95 16.68
PBT 51.98 79.30 -34.45 346.67 589.08 -41.15 346.67 589.08 -41.15
TAX 21.06 18.87 11.61 99.20 156.14 -36.47 99.20 156.14 -36.47
Deferred Tax 3.36 3.87 -13.18 7.00 6.14 14.01 7.00 6.14 14.01
PAT 30.92 60.43 -48.83 247.47 432.94 -42.84 247.47 432.94 -42.84
Equity 92.04 92.03 0.01 92.04 92.03 0.01 92.04 92.03 0.01
PBIDTM(%) 10.65 16.77 -36.52 14.74 22.29 -33.84 14.74 22.29 -33.84

Themis Medicare Share Price

90.25 4.97 (5.83%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×